Xavier Duportet

Xavier Duportet is a multifaceted entrepreneur and scientist with a strong background in biotechnology and innovation. He currently serves as a Member of the Strategic Advisory Board at Université Paris-Saclay, which is ranked 14th in the world and 1st in Europe according to the Shanghai Ranking.1

Professional Experience

Duportet is primarily known for his role as the Co-founder and CEO of Eligo Bioscience, a company he established in June 2014. Eligo Bioscience is pioneering first-in-class in vivo CRISPR and gene editing modalities to address serious diseases in immuno-inflammation and oncology.1

In addition to his work at Eligo Bioscience, Duportet has several other notable positions:

• Co-founder and President of Deeptech Founders: An acceleration program for entrepreneurial scientists from leading French research institutions.1
• Member of the Scientific Advisory Board at Universcience.1
• Honorary President of Hello Tomorrow: An organization he founded and led from 2014 to 2019, aimed at bridging the gap between science and business.1
• Co-founder and Board Member of Green Spot Technologies: A company transforming agricultural by-products into nutritious functional flours.1

Education and Achievements

Duportet's educational background includes studies at the Massachusetts Institute of Technology (MIT) from 2010 to 2014.1 His innovative work has earned him several accolades:

• MIT T35 - French Innovator of the Year by MIT Technology Review in 2015.1
• Laureate of the Worldwide Innovation Challenge by the French Government in 2014.1
• Grand Prize - PhD-Entrepreneur of the Year Award in 2014.1

Current Focus

As of 2024, Duportet continues to be passionate about molecular medicine and translational medicine, dedicating his efforts to improving patient and family lives through innovative biotechnology approaches.2 His work at Eligo Bioscience combines microbiome research and gene editing, performing in vivo microbial genome engineering.3

Xavier Duportet's diverse roles and achievements demonstrate his significant contributions to the fields of biotechnology, entrepreneurship, and scientific innovation.